drugset
drugset / Trial / NCT04479800

Effect of Food on the Pharmacokinetics of ASTX660 in Healthy Volunteers

NCT04479800 ↗

Phase 1 Completed 21 enrolled Astex Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

This is a Phase 1, single-dose, open-label, randomized, three-period, three-way crossover study in which healthy adult participants will receive three separate single-dose administrations of ASTX660 capsules under three different conditions.

Timeline

Start
2020-07-20
Primary completion
2020-08-25
Completion
2020-08-25

Drugs

EvaluationDrugModalityDoseRoute
Subject ASTX660 Small molecule — Oral

Indications

No indication recorded.